Rgeno Pharmaceuticals

Manufacturing and supplying pharmaceutical products in India.

About Rgeno Pharmaceuticals

Rgeno Pharmaceuticals is a Healthcare company. Manufacturing and supplying pharmaceutical products in India. Its Indian entity Rgeno Pharmaceuticals Private Limited reported revenue of β‚Ή1.6 Lakh. Rgeno Pharmaceuticals offers products and services including RGMOX 1 GM Tablet and G FLAM SP Tablet. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Medical Supplies.

Company details

Rgeno Pharmaceuticals Pvt. Ltd. is recognized for having built trust among numerous customers through the production of pharmaceutical products using quality materials and advanced technologies that align with industry standards. A commitment to providing high-standard services to retailers and customers is maintained, while adapting to changes in the market. The company is noted for its inventory of tablets, injections, and syrups, which are made available for inquiries, emphasizing reliability and adherence to excellence in operations.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website rgenopharma.com
  • Legal Name Rgeno Pharmaceuticals Pvt. Ltd
  • Date of Incorporation 18 Jan, 2018
  • Jurisdiction Navi Mumbai, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹1.6 Lakh

    FY 2024 · -41% YoY

  • Indian entity net profit
    ₹5,545

    FY 2024 · 3% margin

  • Indian entity EBITDA
    ₹9,843

    FY 2024 · 6% margin

Products & Services of Rgeno Pharmaceuticals

Rgeno Pharmaceuticals offers a comprehensive portfolio of products and services, including RGMOX 1 GM Tablet and G FLAM SP Tablet.

RGMOX 1 GM Tablet
Pharmaceutical Products

RGMOX 1 GM Tablet is manufactured as a pharmaceutical product for health purposes, utilizing quality materials to meet industry standards

G FLAM SP Tablet
Pharmaceutical Products

G FLAM SP Tablet is produced as another pharmaceutical offering, designed to align with established health requirements

Board of directors of Rgeno Pharmaceuticals Private Limited (Rgeno Pharmaceuticals)

Rgeno Pharmaceuticals Private Limited is the primary company behind Rgeno Pharmaceuticals. The board of Rgeno Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Dilip Kumar, appointed in 2018.

DirectorDesignationAppointedTenureEntity
Dilip Kumar
DIN 08011563
Director18 Jan 20188 yrs 10 moRgeno Pharmaceuticals Private Limited
Deepak Kumar
DIN 08011557
Director18 Jan 20188 yrs 10 moRgeno Pharmaceuticals Private Limited

Financials of Rgeno Pharmaceuticals

Figures of Rgeno Pharmaceuticals Private Limited, the primary company behind Rgeno Pharmaceuticals, for FY 2024. Revenue was ₹1.6 Lakh (-41% year on year). Net profit was ₹5,545 (3% margin). EBITDA was ₹9,843 (6% margin). Revenue has grown at a compounded annual rate of -29% over three years and +30% over five years.

  • ₹1.6 LakhRevenue · FY 2024 · -41% YoY
  • ₹5,545Net profit · 3% margin
  • ₹9,843EBITDA · 6% margin
  • ₹5 LakhPaid-up capital
  • -29%Revenue CAGR, 3 years
  • +30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rgeno Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Rgeno Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Rgeno Pharmaceuticals

The primary company behind Rgeno Pharmaceuticals, Rgeno Pharmaceuticals Private Limited, reported revenue of β‚Ή1.6 Lakh for FY 2024, down 41% year on year.

Rgeno Pharmaceuticals Pvt. Ltd. is recognized for having built trust among numerous customers through the production of pharmaceutical products using quality materials and advanced technologies that align with industry standards. A commitment to providing high-standard services to retailers and customers is maintained, while adapting to changes in the market. The company is noted for its inventory of tablets, injections, and syrups, which are made available for inquiries, emphasizing reliability and adherence to excellence in operations.

Rgeno Pharmaceuticals offers RGMOX 1 GM Tablet and G FLAM SP Tablet.

Rgeno Pharmaceuticals operates through Rgeno Pharmaceuticals Private Limited.

The legal entities of Rgeno Pharmaceuticals currently have 2 directors, including Dilip Kumar, Deepak Kumar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available